Latest filing published 04 Aug 2026 for Immunome Inc., €2.0M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Horn Kinney discloses dealings in Immunome Inc. to SEC (Form 4). Over a trading history stretching from 7 July 2026 to 4 August 2026, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 4 August 2026, reports a transaction of €2.0M in Immunome Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations